In addition, pre-treatment with recombinant Klotho (200 pM) significantly prevented oxidized low-density lipoprotein-induced oxidative stress in HUVECs (29), indicating that Klotho might protect against CAD through its antioxidant effects. Here, KL is linked to coronary artery disorder.